Judge Potentially Limits Claims in Avandia MDL
A Pennsylvania federal judge on Tuesday set a deadline date for heart disease claims against GlaxoSmithKline PLC over diabetes drug Avandia, which could retroactively reduce the number of claims in a...To view the full article, register now.
Already a subscriber? Click here to view full article